Vident Advisory’s Trueblue TBI Stock Holding History

Vident Advisory’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$112K	Hold	16,053	–	–	﹤0.01%	1879
2026 Q1	$62.8K	Buy	+16,053	New	+$71.3K	﹤0.01%	1810

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IES Holdings Houston, Texas $311M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vident Advisory's TBI Position: Q2 2026 in Review

Vident Advisory held its Trueblue (TBI) position steady in Q2 2026 at 16,053 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

Vident Advisory first reported a position in TBI in Q1 2026 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

Vident Advisory held 16,053 shares of Trueblue worth $112K as of Q2 2026.
Vident Advisory left its Trueblue share count unchanged in Q2 2026.
Trueblue made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1879 holding.
Vident Advisory first reported a position in Trueblue in Q1 2026 and has held it in 2 quarters since.
113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.